IM group N= 3741 | SC group N= 3761 | |
---|---|---|
Number of subjects (%)2 | ||
Systemic adverse event | 295 (78.9) | 295 (78.5) |
Vaccine-related systemic adverse event | 156 (41.7) | 156 (41.5) |
Related to M-M-RvaxPro | 153 (40.9) | 149 (39.6) |
Related to VARIVAX | 121 (32.4) | 125 (33.2) |
Measles-like rash3 | 11 (2.9) | 10 (2.7) |
Mumps-like illness | 0 | 1 (0.3) |
Rubella-like rash3 | 10 (2.7) | 10 (2.7) |
Varicella-like rash3 | 2 (0.5) | 12 (3.2) |